Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01900925 · ClinicalTrials.gov registry record · Phase 2
Does Prescriptive Treatment of the Hips Improve Outcomes in Patients With Low Back Pain? A Randomized Controlled Trial
A Phase 2 study, sponsored by Regis University.
- Completed
- Registry status
- Phase 2
- Development phase
- 90
- Enrollment target
NCT01900925: Completed Phase 2 study, sponsored by Regis University.
NCT01900925 is a Phase 2 study that has completed, run by Regis University. The registered enrollment target is 90 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (32% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01900925, a Phase 2 study, has completed, sponsored by Regis University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 90 participants
- Enrollment target
Study Summary
There will be two groups of patients with low back pain (by randomization). Both groups will receive a pragmatic treatment approach by physical therapists for low back pain. One group will also receive a prescriptive treatment approach for both hips. The investigators feel that the additional of a standardized exercise program and stretching for the hips will improve outcomes in patients with mechanical low back pain.
Primary Outcome
The Modified Oswestry Disability Index (ODI) will be used to measure disability, will serve as the primary outcome measure for the study, and consists of 10 questions each scored from 0 to 5, with higher scores indicating greater disability. A 50% reduction in the ODI or greater from baseline has been considered a clinically important outcome.
Interventions
- PROCEDURE Prescriptive Hip Exercises and Manual Therapy techniques
- PROCEDURE Pragmatic low back pain treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2013-09 |
| Est. Completion | 2016-03 |
| Phase | Phase 2 |
What the finished NCT01900925 record still lists
NCT01900925 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (32% lower).
The record links to 0 conditions, and to 2 interventions - of which Prescriptive Hip Exercises and Manual Therapy techniques is the first listed.
NCT01900925 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01900925 about?
NCT01900925 is a clinical study titled "Does Prescriptive Treatment of the Hips Improve Outcomes in Patients With Low Back Pain? A Randomized Controlled Trial". There will be two groups of patients with low back pain (by randomization). Both groups will receive a pragmatic treatment approach by physical therapists for low back pain. One group will also receive a prescriptive treatment approach for both hips. The investigators feel that the additional of a s...
What is the current status of trial NCT01900925?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 90 participants. The study started on 2013-09. Estimated completion is 2016-03.
What interventions are being tested in trial NCT01900925?
The interventions under investigation include: Prescriptive Hip Exercises and Manual Therapy techniques (PROCEDURE), Pragmatic low back pain treatment (PROCEDURE).
Who is sponsoring clinical trial NCT01900925?
This trial is sponsored by Regis University, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01900925's enrollment target sits among peer trials
90 772nd of 2000 higher than 1,199 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia